Cargando…

Targeting IL-17 for pancreatic cancer prevention

Detalles Bibliográficos
Autores principales:	McAllister, Florencia, Leach, Steven D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2014
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259416/ https://www.ncbi.nlm.nih.gov/pubmed/25393980

Ejemplares similares

Therapeutic potential of microbial modulation in pancreatic cancer
por: Chandra, Vidhi, et al.
Publicado: (2021)

Dicer Is Required for Maintenance of Adult Pancreatic Acinar Cell Identity and Plays a Role in Kras-Driven Pancreatic Neoplasia
por: Wang, Yue J., et al.
Publicado: (2014)

Immune cells in pancreatic cancer: Joining the dark side
por: Zhang, Yaqing, et al.
Publicado: (2014)

The Human Microbiomes in Pancreatic Cancer: Towards Evidence-Based Manipulation Strategies?
por: Brandi, Giovanni, et al.
Publicado: (2021)

Immunotherapy in Pancreatic Adenocarcinoma: Beyond “Copy/Paste”
por: Hester, Robert, et al.
Publicado: (2021)

Profiling and targeting of cellular bioenergetics: inhibition of pancreatic cancer cell proliferation
por: Cheng, G, et al.
Publicado: (2014)

Nicotinamide riboside or IL-17A signaling blockers to prevent liver disorders
por: Teijeiro, Ana, et al.
Publicado: (2017)

Targeting IL-17B–IL-17RB signaling with an anti–IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokines
por: Wu, Heng-Hsiung, et al.
Publicado: (2015)

Mechanistic Insights into the Roles of the IL-17/IL-17R Families in Pancreatic Cancer
por: Chen, Zheng, et al.
Publicado: (2023)

IL-17 in spondyloarthritis: is the T-party over?
por: Yeremenko, Nataliya, et al.
Publicado: (2011)

Transforming the Approach to Cell‐Based Therapies
por: Atala, Anthony, et al.
Publicado: (2017)

Interleukin-17–induced neutrophil extracellular traps mediate resistance to checkpoint blockade in pancreatic cancer
por: Zhang, Yu, et al.
Publicado: (2020)

Too much water drowned the miller: Akkermansia determines immunotherapy responses
por: Li, Le, et al.
Publicado: (2022)

The IL-17A/IL-17RA Axis Is Not Related to Overall Survival and Cancer Stem Cell Modulation in Pancreatic Cancer
por: Li, Jiahui, et al.
Publicado: (2020)

Kras mutation rate precisely orchestrates ductal derived pancreatic intraepithelial neoplasia and pancreatic cancer
por: Singh, Kanchan, et al.
Publicado: (2020)

Correction to: Kras mutation rate precisely orchestrates ductal derived pancreatic intraepithelial neoplasia and pancreatic cancer
por: Singh, Kanchan, et al.
Publicado: (2021)

Right on the Nose: IL-17C and Nasal Host Defense
por: Zemke, Anna C., et al.
Publicado: (2020)

Secukinumab: The Anti-IL-17A Biologic for the Treatment of Psoriasis
por: Fargnoli, Maria Concetta
Publicado: (2019)

Inflammation, cytokines, the IL-17/IL-6/STAT3/NF-κB axis, and tumorigenesis
por: Chen, Xiao-Wu, et al.
Publicado: (2015)

Bacterial and fungal characterization of pancreatic adenocarcinoma from Endoscopic Ultrasound-guided biopsies
por: Wright, Robin D., et al.
Publicado: (2023)

Tumor Spheres Quantification with Smoothed Euclidean Distance Transform
por: Sahin, Ismet, et al.
Publicado: (2018)

Targeting interleukin-17 receptors
por: Lee, Wen-Hwa, et al.
Publicado: (2015)

The role of intestinal microbiota, bile acids, and Th17/IL17 axis in hepatitis B virus-related liver fibrosis
por: Chen, Yan-Fei, et al.
Publicado: (2020)

Therapeutic potential of targeting mirnas to prostate cancer tumors: using psma as an active target
por: Yarahmadi, Amir, et al.
Publicado: (2022)

IL-17B/RB Activation in Pancreatic Stellate Cells Promotes Pancreatic Cancer Metabolism and Growth
por: Li, Jiahui, et al.
Publicado: (2021)

Th17 Cells and IL-17 As Novel Immune Targets in Ovarian Cancer Therapy
por: Bilska, Monika, et al.
Publicado: (2020)

Therapeutic potential of targeting IL-17 and IL-23 in sepsis
por: Bosmann, Markus, et al.
Publicado: (2012)

Pathogenic Role of IL-17 and Therapeutic Targeting of IL-17F in Psoriatic Arthritis and Spondyloarthropathies
por: Sánchez-Rodríguez, Guillermo, et al.
Publicado: (2023)

TPL2 mediates IL-17R signaling in neuroinflammation
por: Xiao, Yichuan, et al.
Publicado: (2015)

Cyr61/CCN1 targets for chemosensitization in pancreatic cancer
por: Banerjee, Snigdha, et al.
Publicado: (2019)

The Emerging Role of the IL-17B/IL-17RB Pathway in Cancer
por: Bastid, Jérémy, et al.
Publicado: (2020)

Targeting IL-11 signaling in colon cancer
por: Ernst, Matthias, et al.
Publicado: (2013)

The role of Th17 cells/IL-17A in AD, PD, ALS and the strategic therapy targeting on IL-17A
por: Fu, Jiajia, et al.
Publicado: (2022)

Pharmacological Rationale for Targeting IL-17 in Asthma
por: Rahmawati, Siti Farah, et al.
Publicado: (2021)

Targeting MUC4 in pancreatic cancer: miRNAs
por: Jonckheere, Nicolas, et al.
Publicado: (2015)

A Theranostic Approach to Target Gastrin in Pancreatic Cancer
por: Banerjee, Sulagna, et al.
Publicado: (2018)

Mechanisms of resistance to mitochondria-targeted therapy in pancreatic cancer
por: Boukalova, Stepana, et al.
Publicado: (2021)

Serum concentrations of IL-17A, IL-17B, IL-17E and IL-17F in patients with systemic sclerosis
por: Robak, Ewa, et al.
Publicado: (2019)

Pancreatic cancer driver mutations are targetable through distant alternative RNA splicing dependencies
por: Kawalerski, Ryan R., et al.
Publicado: (2021)

Hyperpolarized Magnetic Resonance and Artificial Intelligence: Frontiers of Imaging in Pancreatic Cancer
por: Enriquez, José S, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ue95fe6jji95kd5l0rmqjt460b